Can B Corp (NASC) stock: key figures, P/E, revenue and dividend

Industrials · United States

Price
0.01 USD
Market cap
992,383.30 USD
P/E (2024)
–
P/S (2024)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

Can B Corp financials

Fiscal year2023
Revenue2.16 m USD
Gross profit358,698.00 USD
Operating income-7.49 m USD
EBIT-7.22 m USD
Net income-9.74 m USD
Diluted EPS – continuing operations-0.77 USD

Full history since 2014, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Can B Corp

Nascent Pharma Holdings, Inc. engages in the protection and commercialization of cannabis patents. It produces superfood drink mix products under the Longevity brand name. The company was formerly known as Can B Corp. and changed its name to Nascent Pharma Holdings, Inc. in September 2025. Nascent Pharma Holdings, Inc. was incorporated in 2005 and is based in Hicksville, New York.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.